Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f0fcce2823e49658311046582f86dfa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2993051beef8a2f0934d25016304a02 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2250-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2307-3065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-24752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H02G3-0481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-1362 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2457-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-1369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2307-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B2262-0276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B5-024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B32B5-022 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B32B3-00 |
filingDate |
2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74df0b6c9daa37ece0e448717b6686a1 |
publicationDate |
2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007079400-A3 |
titleOfInvention |
Self-adhesive protective substrate |
abstract |
The present invention relates to compounds and methods useful as inhibitors of protein kinases, including B-Raf and several receptor tyrosine and cytoplasmic tyrosine kinases. The present invention is directed to new substituted pyrimidinyloxy urea compounds of Formulas II, III and IV and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulating of protein kinase activity in a human or animal subject are also provided for the treatment diseases such as cancers. |
priorityDate |
2005-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |